HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delphine Chu Miow Lin Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

4/2010Trough infliximab concentrations predict efficacy and sustained control of disease activity in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Delphine Chu Miow Lin Research Topics

Disease

1Rheumatoid Arthritis
04/2010

Drug/Important Bio-Agent (IBA)

1Infliximab (Remicade)FDA Link
04/2010
1Monoclonal AntibodiesIBA
04/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010